Boothbay Fund Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Boothbay Fund Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,916	Closed	-$25K	–	2934
2022 Q1	$25K	Hold	19,916	–	–	﹤0.01%	2223
2021 Q4	$23K	Hold	19,916	–	–	﹤0.01%	1798
2021 Q3	$38K	Sell	19,916 -3,179	-14%	-$6.25K	﹤0.01%	1844
2021 Q2	$54K	Buy	+23,095	New	+$55.7K	﹤0.01%	1765

Other funds holding GNCA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Boothbay Fund Management's GNCA Position: Q2 2022 in Review

Boothbay Fund Management sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 19,916 shares — an estimated $25K sold.

Boothbay Fund Management first reported a position in GNCA in Q2 2021 and held it in 4 quarters. The position peaked at $54K in Q2 2021. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

Boothbay Fund Management reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Boothbay Fund Management sold 19,916 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $25K.
Boothbay Fund Management first reported a position in Genocea Biosciences, Inc. in Q2 2021 and held it in 4 quarters.
Boothbay Fund Management's Genocea Biosciences, Inc. position peaked at $54K in Q2 2021.
5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.